市场调查报告书
商品编码
1483681
口腔癌快速检测套组市场 - 全球规模、份额、趋势分析、机会、预测报告,2019-2030Oral Cancer Rapid Test Kit Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Type; By End User; By Region |
全球口腔癌快速检测套组市场规模将以复合年增长率6.03%扩大,2030年将达12亿美元
由于对市场开拓的投资以及口腔癌诊断设备和套件的引进的日益重视,全球口腔癌快速检测套组市场正在蓬勃发展。
领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计,2023 年全球口腔癌快速检测套组市场规模将达到 9.8776 亿美元。 BlueWeave预测,在2024-2030年的预测期内,口腔癌快速检测套组的全球市场规模将以6.03%的复合年增长率成长,到2030年将达到11.8423亿美元。由于烟草和酒精消费量的增加,口腔癌的盛行率不断增加,生物感测器技术等检测套组的进步是全球口腔癌快速检测套组市场的主要成长动力。此外,随着人们对癌症筛检的认识不断提高,预计口腔癌快速检测套组的全球市场将受到推动。
机会研究和发展计划扩展
针对全球口腔癌发生率不断上升的情况,各国政府、研究机构和私人公司正在大力投资研发工作,以准确诊断癌症。例如,根据《国际癌症杂誌》发表的一项研究,伦敦大学玛丽女王学院的研究人员声称开发了有史以来第一个针对口腔癌的 PCR 检测方法。在分析期间,此类市场开拓预计将为全球口腔癌快速检测套组市场的主要企业提供利润丰厚的成长机会。
地缘政治紧张局势加剧对全球口腔癌快速检测套组市场的影响
地缘政治紧张局势的加剧阻碍了全球口腔癌快速检测套组市场的成长。例如,乌克兰的癌症负担很高,每年约有16万人新诊断出癌症。然而,俄罗斯入侵乌克兰对医疗基础设施造成重大破坏,导致医疗保健专业人员和癌症患者移民到邻国。由于缺乏医疗服务,包括口腔癌在内的癌症诊断数量大幅下降。巴勒斯坦也出现了类似的情况,加萨唯一的癌症医院因以色列军事占领而缺乏燃料而关闭。
全球口腔癌快速检测套组市场
按细分市场分類的覆盖范围
口腔癌快速检测套组的全球市场 - 按类型
按类型划分,全球口腔癌快速检测套组市场分为 OncAlert 口腔癌 LAB、晶片实验室和 Prevo-check。 OncAlert口腔癌LAB在全球口腔癌快速检测套组市场中占有最大份额,预计在预测期内将实现较高的复合年增长率。这种经济实惠的测试易于使用,不需要对患者进行侵入性操作,并且提供的观察易于医生理解。所有成年人都可以从准确且负担得起的检测中受益,但目前或以前使用烟草製品、过度饮酒或感染 HPV-16 的高风险族群(例如人类)可能受益最多。
全球口腔癌快速检测套组市场(按地区)
关于全球口腔癌快速检测套组市场的详细研究报告涵盖了北美、欧洲、亚太地区(APAC)、拉丁美洲和中东非洲五个主要地区的众多各国市场。由于癌症筛检率高以及 Viome、雅培实验室和赛默飞世尔科技等主要企业的集中,北美在口腔癌快速检测套组的全球市场中占据主导地位。由于亚太地区和欧洲的口腔癌盛行率不断上升,预计在预测期内这些地区的成长率将显着增加。
竞争格局
全球口腔癌快速检测套组市场的主要公司有 Viome Life Sciences、Vigilant Biosciences、Grail、Abbott Laboratories、F. Hoffmann-La Roche AG、Siemens Healthineers AG、Thermo Fisher Scientific Inc.、Quidel Corporation、Bio-Rad Laboratories, Inc.、丹纳赫公司、Henry Schein, Inc.、Becton、Dickinson and Company 和Quest Diagnostics Incorporated。
为了进一步增加市场占有率,这些公司正在采取各种策略,例如併购、合作、合资、授权合约和新产品发布。
该报告的详细分析提供了有关成长潜力、未来趋势和全球口腔癌快速检测套组市场的资讯。我们也关注推动市场总规模预测的因素。该报告承诺提供全球口腔癌快速检测套组市场的最新技术趋势以及行业见解,以帮助决策者做出明智的策略决策。此外,也分析了市场的成长动力、挑战和竞争动态。
Global Oral Cancer Rapid Test Kit Market Size Expands at Significant CAGR of 6.03% to Touch Whopping USD 1.2 Billion by 2030
Global Oral Cancer Rapid Test Kit Market is flourishing because of the growing focus on investments in the development and adoption of diagnostic equipment and kits for oral cancer.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Oral Cancer Rapid Test Kit Market size at USD 987.76 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Oral Cancer Rapid Test Kit Market size to expand at a CAGR of 6.03% reaching a value of USD 1,184.23 million by 2030. The increased incidence of oral cancer as a result of rising tobacco and alcohol consumption and advancements in testing kits, such as those in biosensor technology, are key growth drivers for the Global Oral Cancer Rapid Test Kit Market. Moreover, it is projected that the Global Oral Cancer Rapid Test Kit Market will be driven by growing awareness that will result in more cancer screenings.
Opportunity: Expanding research and development programs
Governments, research institutions, and private companies are heavily investing in research and development activities to accurately diagnose cancer in response to the rising incidence of mouth cancer worldwide. For example, research published in the International Journal of Cancer claims that researchers at Queen Mary University of London have developed the first-ever PCR test for mouth cancer. Such developments are anticipated to present lucrative growth opportunities for the major players in the Global Oral Cancer Rapid Test Kit Market during the period in analysis.
Impact of Escalating Geopolitical Tensions on Global Oral Cancer Rapid Test Kit Market
The escalating geopolitical tensions disrupted the growth of the Global Oral Cancer Rapid Test Kit Market. For instance, Ukraine has a high cancer burden with approximately 160,000 newly diagnosed patients with cancer each year. However, Russia's invasion of Ukraine resulted in significant damage to medical infrastructure and the migration of both healthcare professionals and cancer patients to neighboring countries. The inaccessibility of medical services led to a significant decline in cancer diagnoses, including oral cancer. Palestine witnessed a similar situation as well when Israel's military occupation of the country resulted in the shutting down of Gaza's only cancer hospital due to a fuel shortage.
Global Oral Cancer Rapid Test Kit Market
Segmental Coverage
Global Oral Cancer Rapid Test Kit Market - By Type
Based on type, the Global Oral Cancer Rapid Test Kit Market is divided into OncAlert oral cancer LAB, lab on a chip, and Prevo-check. OncAlert Oral Cancer LAB holds the largest share in the Global Oral Cancer Rapid Test Kit Market and is anticipated to register a high CAGR during the forecast period as well. This affordable test is simple to use, does not require intrusive procedures from the patient, and gives physicians findings that are straightforward to understand. All adults can benefit from the precise, affordable tests, but high-risk groups-such as those who use tobacco products now or in the past, drink excessively, or have HPV-16-may benefit most.
Global Oral Cancer Rapid Test Kit Market - By Region
The in-depth research report on the Global Oral Cancer Rapid Test Kit Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Oral Cancer Rapid Test Kit Market owing to its high cancer screening rate and high concentration of leading industry players, including Viome, Abbott Laboratories, and Thermo Fisher Scientific Inc. Asia Pacific and Europe are anticipated to register significant growth rates during the forecast period as well owing to the increasing prevalence of oral cancer in these regions.
Competitive Landscape
Major players operating in the Global Oral Cancer Rapid Test Kit Market include Viome Life Sciences, Vigilant Biosciences, Grail, Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Quidel Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Henry Schein, Inc, Becton, Dickinson and Company, and Quest Diagnostics Incorporated.
To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Oral Cancer Rapid Test Kit Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Oral Cancer Rapid Test Kit Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
Tables